CD19-BCMA Dual Nanobody Based CAR-T Cells for Patients With DSA
NCT07451236
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
NOT_YET_RECRUITING
Status
18
Enrollment
OTHER
Sponsor class
Conditions
Transplantation Candidates With Hematological Diseases
Interventions
BIOLOGICAL:
CD19-BCMA dual nanobody based CAR-T Cells
Sponsor
Chang Yingjun